Steroid withdrawal syndrome after successful treatment of Cushing's syndrome: A reminder

European Journal of Endocrinology

Volumn 153, Issue 2, 2005, Pages 207-210

  Bhattacharyya, A ^b   Kaushal, K ^b   Tymms, D J ^a   Davis, Julian R E ^b  

^a ROYAL ALBERT EDWARD INFIRMARY   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DOPAMINE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 6; NORADRENALIN; VASOPRESSIN;

ADRENAL CORTEX ADENOMA; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADENOMA; LOW DRUG DOSE; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RELAPSE; RISK REDUCTION; WITHDRAWAL SYNDROME;

ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADULT; CUSHING SYNDROME; DRUG TOLERANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 23844434012     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01953     Document Type: Article

References (15)

1. Dixon RB & Christy NP. On the various forms of corticosteroid withdrawal syndrome. American Journal of Medicine 1980 68 224-230.
2. George CF & Robertson D. Clinical consequences of abrupt drug withdrawal. Medical Toxicology and Adverse Drug Experience 1987 2 367-382.
3. Hochberg Z, Pacak K & Chrousos GP. Endocrine withdrawal syndromes. Endocrine Reviews 2003 24 523-538.
4. Amatruda TT Jr, Hurst MM & D'Esopo ND. Certain endocrine and metabolic facets of the steroid withdrawal syndrome. Journal of Clinical Endocrinology and Metabolism 1965 25 1207-1217.
5. Swartz SL & Dluhy RG. Corticosteroids: clinical pharmacology and therapeutic use. Drugs 1978 16 238-255.
6. Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clinical Endocrinology 1997 46 263-268.
7. Amatruda TT Jr, Hollingsworth DR, D'Esopo ND, Upton GV & Bondy PK. A study of the mechanism of the steroid withdrawal syndrome. Evidence for integrity of the hypothalamic-pituitary-adrenal system. Journal of Clinical Endocrinology and Metabolism 1960 20 339-354.
8. Tyrrell JB. Glucocorticoid therapy. In Endocrinology and Metabolism, edn 3, ch. 15, pp 855-882. Eds P Felig, JD Baxter & LA Frohman. New York: McGraw-Hill, Inc., 1995.
9. Papanicolaou DA, Tsigos C, Oldfield EH & Chrousos GP. Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? Journal of Clinical Endocrinology and Metabolism 1996 81 2303-2306.
10. Papanicolaou DA, Wilder RL, Manolagas SC & Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Annals of Internal Medicine 1998 128 127-137.
11. Orth DN & Kovaks WJ. The Adrenal Cortex. In Williams Textbook of Endocrinology, edn 9, ch. 12, pp 517-664. Eds JD Wilson, DW Foster, HM Kronenberg & PR Larsen. Philadelphia: WB Saunders Company, 1998.
12. Miller WL & Tyrrell JB. The adrenal cortex. In Endocrinology and Metabolism, edn 3, ch. 12, pp 555-711. Eds P Felig, JD Baxter & LA Frohman. New York: McGraw-Hill, Inc., 1995.
13. Cook D. The Cushing's Newsletter. February 1999.
14. Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R & Weetman AP. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical Endocrinology 1997 46 255-261.
15. Trainer P, Newell-Price J & Besser M. Cushing's syndrome. In Endocrinology and Diabetes, edn 1, ch. 5.9, pp 817-829. Eds JAH Wass & SM Shalet. Oxford: Oxford University Press, 2002.